Findings underpin potential of Anavex’ lead candidate blarcamesine through its upstream mechanism of action and SIGMAR1-mediated autophagy restorationNEW YORK, March 20, 2026 (GLOBE NEWSWIRE) -- ...
FDA approval of CARDAMYST represents first new option in 30 years for the more than two million patients with PSVTParticipants using CARDAMYST in ...
New data show that blarcamesine completely rescued impaired motor function Biomarker of nerve fiber density of dopaminergic nerve cells indicating fiber regrowth in striatum with blarcamesine New ...
Scientists in China have developed a "capsule" delivery system to transplant healthy mitochondria into diseased cells, a breakthrough that could lead to new treatments for Parkinson's disease, rare ...
The approach harnesses the power of bacteria to transform post-consumer plastic into L-DOPA, a frontline medication for the neurological disorder.
Researchers at the University of Missouri may have found a clue to help uncover a possible link between autism and Parkinson's disease.
Chinese scientists have created a safe and efficient method for transplanting mitochondria — the powerhouse resident of cells containing DNA — in a way that promises to significantly improve symptoms ...
Gadget Review on MSN
Engineered bacteria turn plastic waste into a Parkinson's disease drug ingredient
Scientists at University of Edinburgh engineered bacteria to convert plastic bottles into L-DOPA, a Parkinson's medication, ...
MedPage Today on MSN
The Biggest Mistake People Make on the Toilet
Dr. Mike and Trisha Pasricha, MD, breakdown bathroom habits ...
A research team from the Guangzhou Institutes of Biomedicine and Health under the Chinese Academy of Sciences, Guangzhou Medical University and other institutions, utilized membrane vesicles from red ...
Old PET plastic packaging gets a second life through genetically engineered bacteria – as L-DOPA for Parkinson's patients.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results